跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SITAG-50 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
SITAG-50
Approved
STANDARD
SITAG-50
Bafna Pharmaceuticals Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a2f700febf834c91
Company
Bafna Pharmaceuticals Ltd.
Type
Standard
Approval Details
Approval Id
a2f700febf834c91
Drug Approval Philippines Name
SITAG-50
Product Name
SITAG-50
Registration Number
DRP-6383
Brand Name
SITAG-50
Generic Name
SITAGLIPTIN (as phosphate monohydrate)
Dosage Form
Film-Coated Tablet
Dosage Strength
50mg
Manufacturer
Bafna Pharmaceuticals Ltd.
Importer
MedEthix, Inc.
Distributor
Corbridge Group Phils. Inc.
Issuance Date
24 January 2025
Expiry Date
09 October 2025
Pharmacologic Category
Oral Hypoglycemic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a2f700febf834c91
Type
Standard
Back to Philippines FDA Approvals